STAT+: Pharmalittle: We’re reading about the 340B drug pilot program, an obesity drug disappointment, and more

The U.S. approved 10 drugmakers to participate in a 340B pilot program that will allow them to offer rebates, instead of upfront discounts, to certain providers

≈